AVH 4.67% $3.14 avita medical inc.

us demand, page-25

  1. 62 Posts.
    "Just to add, first FDA Phase 3 wraps up December, expected approval date June/July next year."

    Not to sure where you get this from but their own last CEO presentation states they will only be submitting in June/July 2013

    FDA submission for ReCell in burns Mid 2013

    Go back through all their presentations for the last 2 years and have a look at how many times the dates have blown out. 18 Months and counting now.



 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.